Oncologist and cancer outcomes researcher at the @UofOklahoma @OUCollegeofMed @StephensonCC || Passionate about improving cancer care || #PallOnc #GeriOnc
Oklahoma City, OK
- Tweets 4,923
- Following 573
- Followers 4,662
- Likes 10,067
Association Between Patient-Reported Outcomes and Health Care Resource Utilization: Toward Developing Patient-Centered Value Measures in #Cancer Care.
ascopubs.org/doi/10.1200/JCO…
@ASCO @JCO_ASCO @JCOOP_ASCO
#PallOnc #SuppOnc #CancerCare
4
22
1,012
Cancer Biologics Utilization After Biosimilar Entry and Financial Implications For Payers and Patients.
jamanetwork.com/journals/jam…
@JAMA_current @JAMANetwork @JAMAOnc
#CancerCare #FinancialToxicity #CancerResearch
3
7
350
Abstract titles for #ASCOQLTY26 are live! Here’s a first look at the latest research on quality, safety, and efficiency in cancer care delivery that will be presented at the Symposium: bit.ly/3S7AJbu
7
11
3,056
Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Excellent work on the mechanism of Geriatric Assessment in improving
outcomes for older adults with cancer!
A pleasure working with @crisbergerot , @RyanNipp , @PauloBergerot , and the @cityofhope #GeriOnc team.
Thanks to @AGSJournal for bringing this work out.
@myCARG
GA identifies impairments & may change how older adults cope w cancer @AGSJournal
GAIN-S increased approach-oriented coping, mediating
🔹31% of the improvement in depressive symptoms
🔹18% of the improvement in QOL
📍Potential mechanism of GA benefit
agsjournals.onlinelibrary.wi…
3
5
443
Ryan Nipp, MD, MPH, MBA, FASCO retweeted
📢 Abstract titles for #ASCOQLTY26 are now live on @ASCO’s Digital Program!
Explore the latest research across Cost & Value, Health Care Access, Palliative Care, Patient Experience, Quality & Safety, Survivorship, and Technology & Innovation
asco.org/quality/search?filt…
10
19
1,812
Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Happy to see our GAIN-S study published in @AGSJournal!
GA may go beyond identifying impairments, enhancing approach-oriented coping may be one mechanism through which it improves outcomes
Many thanks to @WilliamDale_MD @RyanNipp @Areejmd @EnriqueSoto8 @PauloBergerot
1
4
9
431
Federal and Industry Sponsorship in US #Cancer Clinical Trials.
jamanetwork.com/journals/jam…
@JAMA_current @JAMANetwork @JAMAOnc
#CancerResearch #ClinicalTrials
@DrJoeUnger @DrDawnHershman
9
20
1,269
The best care is collaborative. 🤝 Don’t miss your chance to join the premier community dedicated to elevating the patient experience. Secure your spot at #ASCOQLTY26 in Boston and save with early bird rates by August 26: bit.ly/4wTVztN
3
9
3,151
Second-Level Appeals of Denied Anticancer Medication Claims in Medicare Part D.
jamanetwork.com/journals/jam…
@JAMA_current @JAMANetwork @JAMANetworkOpen @JAMAOnc
#CancerCare #CancerResearch
@DrRobinYabroff @DusetzinaS
3
5
457
Understanding #Cancer Clinical Trial Participation in Rural Communities: A Qualitative Focus Group Study.
onlinelibrary.wiley.com/doi/…
@PsyOnc @APOSHQ @crisbergerot
#CancerResearch #ClinicalTrials #RuralHealth
6
10
1,822
AI-based augmentation of oncology clinical trials.
nature.com/articles/s41571-0…
@Nature @NaturePortfolio @NatureRevCancer @NatRevClinOncol
#Cancer #ClinicalTrials #CancerResearch
@ravi_b_parikh
4
9
1,929
Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Among patients with metastatic #BreastCancer, alert-based digital patient-reported outcome monitoring was associated with lower fatigue at 6 months vs usual care, with improvement exceeding the minimal clinically important difference.
ja.ma/45ahy3A
ALT JAMA Oncology RCT: Electronic monitoring with alerts for 909 women with metastatic breast cancer reduced fatigue. A graph shows the intervention group's mean fatigue score dropping below the control group's higher score over 12 months.
1
9
26
2,604
Should Artificial Intelligence Direct Systemic Therapy Decisions in Pancreatic #Cancer?
ascopubs.org/doi/pdf/10.1200…
@ASCO @JCO_ASCO @JCOOP_ASCO
#PancreaticCancer #PancSM #ArtificialIntelligence #CancerResearch
@gabe_a_brooks
1
5
11
739
Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast #Cancer: A Randomized Clinical Trial.
jamanetwork.com/journals/jam…
@JAMA_current @JAMAOnc @JAMANetwork
#PallOnc #SuppOnc #BreastCancer #CancerCare #CancerResearch
6
10
1,350
Drug Costs in Federally Sponsored #Cancer Clinical Trials: A Systematic Review.
jamanetwork.com/journals/jam…
@JAMA_current @JAMANetwork @JAMAOnc @JAMANetworkOpen
#CancerCare #ClinicalTrials #CancerResearch
@DrJoeUnger @DrDawnHershman
7
16
936
Concurrent #Palliative Care and Systemic Treatment Among Young Adults With Advanced #Cancer.
jamanetwork.com/journals/jam…
@JAMA_current @JAMANetwork @JAMAOnc @JAMANetworkOpen
#PallOnc #PalliativeCare
@ACS_Research @DrRobinYabroff @CharlesJiangMD
1
5
13
2,384
Treatment Tolerability in Older Adults With Advanced #Cancer Receiving Geriatric Assessment–Guided Versus Oncologist-Guided Primary Treatment Modification: Secondary Analysis of the GAP70+ Trial.
ascopubs.org/doi/10.1200/OP-…
@ASCO @JCO_ASCO @JCOOP_ASCO
#GeriOnc #SuppOnc #Geriatrics
1
14
34
10,123
Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Proud to see so many terrific friends & colleagues in this photo including @FunchainMD @koshkin85 @thenasheffect @VaiaFlorou & so many others! I had the best time serving as @ASCO LDP mentor for the past 2 years & hope that each of you in this photo has an incredible experience! @StephenChunMD @umangtalking @GitaThanaMD @NVijayvergiaMD @ErinCobain @minasedrakmd @hannawants2ELCN @RyanNipp
Fantastic meeting these @ASCO LDP 2026-27 classmates at ASCO HQ , diversified group with amazing skills and leadership qualities! @FunchainMD @VaiaFlorou @Sarbaji85064063 @koshkin85 @gandhi_shipra and many others off twitter !
2
8
26
2,175
Ryan Nipp, MD, MPH, MBA, FASCO retweeted
Among patients with early age–onset #ColorectalCancer in Texas, treatment delays longer than six weeks were associated with reduced survival, and language barriers represented a major risk factor contributing to delayed initiation of definitive therapy. ja.ma/4fOBC0r
1
15
20
1,819